Related Experiment Video
Updated: Jul 31, 2026

03:53
Extracellular Vesicle Tissue Factor Activity Assay
Published on: December 29, 2023
Native thrombopoietin: structure and function
1Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd., Takasaki, Gunma, Japan.
Stem Cells (Dayton, Ohio)
|October 10, 1998
Summary
Thrombopoietin (TPO) is regulated by its binding to c-Mpl on platelets. While truncated TPO forms exist, full-length TPO predominates in human circulation, suggesting truncation is not key for platelet production regulation.
Area of Science:
- Hematology
- Molecular Biology
- Biochemistry
Background:
- Thrombopoietin (TPO) is crucial for hematopoietic stem cell development and platelet production.
- TPO interacts with its receptor c-Mpl, and its circulating levels are influenced by c-Mpl mass on platelets and megakaryocytes.
- Megakaryocytopoiesis and platelet production may be modulated by TPO activity, potentially through proteolytic processing into truncated forms.
Purpose of the Study:
- To investigate the role of TPO truncation in regulating platelet production.
- To determine the predominant form of TPO in human circulation.
- To assess the physiological significance of TPO truncation.
Main Methods:
- Characterization of TPO purified from human plasma.
- Analysis of TPO forms in normal and thrombocytopenic individuals.
- Comparison of circulating TPO forms with those found in thrombocytopenic animals.
Main Results:
- Full-length TPO was the predominant form in the circulation of both normal and thrombocytopenic humans.
- Small amounts of truncated TPO species were detected in human plasma.
- Native TPO from thrombocytopenic animals contained truncated forms.
Conclusions:
- TPO truncation does not appear to directly regulate platelet production in response to increased demand in humans.
- TPO truncation is likely physiologically important, as evidenced by its presence in thrombocytopenic animal plasma.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

